Jun-Zhu Xu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jun-Zhu Xu has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Li Chai
Department of Dermatology, Hangzhou Third People’s Hospital, Hangzhou, China
1 shared publication - Qingwei Geng
Department of Dermatology, Hangzhou Third People’s Hospital
1 shared publication - Ze-Hu Liu
Department of Dermatology, Hangzhou Third People’s Hospital, Hangzhou Third Hospital Affiliated to Zhejiang Chinese Medical University, Hangzhou, China
1 shared publication - Zhongmei Liu
Department of Endocrinology and Hematology, Hangzhou Third People’s Hospital, Hangzhou City, Zhejiang Province, China
1 shared publication
Latest Publications
- Open Access
- 24 October 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (43) , e45325
Acquired hemophilia A in an elderly female with bullous pemphigoid: Case report
Rationale: Acquired hemophilia A (AHA) is a rare but life-threatening bleeding disorder, necessitating enhanced recognition in patients with concomitant autoimmune diseases. Patient concerns: A 91-year-old female with bullous pemphigoid presented with spontaneous subcutaneous bleeding and prolonged activated partial thromboplastin time. Diagnoses: Laboratory investigations revealed a decrease in factor VIII activity to 6.4%, confirming the diagnosis of bullous pemphigoid-associated AHA. Interventions: The patient was subjected to monotherapy with glucocorticoids and supportive hemostatic measures. Outcomes: Coagulation parameters normalized within 1 month, and no severe complications occurred. Lessons: This case highlights the importance of considering AHA in elderly patients with autoimmune diseases who present with unexplained bleeding. An individualized treatment strategy may improve clinical outcomes.
- 24 October 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (43) , e45325
Open AccessAcquired hemophilia A in an elderly female with bullous pemphigoid: Case report
Rationale: Acquired hemophilia A (AHA) is a rare but life-threatening bleeding disorder, necessitating enhanced recognition in patients with concomitant autoimmune diseases. Patient concerns: A 91-year-old female with bullous pemphigoid presented with spontaneous subcutaneous bleeding and prolonged activated partial thromboplastin time. Diagnoses: Laboratory investigations revealed a decrease in factor VIII activity to 6.4%, confirming the diagnosis of bullous pemphigoid-associated AHA. Interventions: The patient was subjected to monotherapy with glucocorticoids and supportive hemostatic measures. Outcomes: Coagulation parameters normalized within 1 month, and no severe complications occurred. Lessons: This case highlights the importance of considering AHA in elderly patients with autoimmune diseases who present with unexplained bleeding. An individualized treatment strategy may improve clinical outcomes.
- Open Access
- 4 September 2025
- Published by Taylor & Francis in Journal of Dermatological Treatment
- Vol. 36 (1) , 2556487
Abrocitinib combined with low-dose corticosteroids in the management of tattoo-related cutaneous sarcoidosis: a case report
Sarcoidosis is a chronic, multisystem granulomatous disorder characterized histologically by non-caseating granulomas. Despite the availability of various therapeutic options, long-term disease control remains a significant clinical challenge. We report the case of a 55-year-old female diagnosed with sarcoidosis. Skin and lymph node biopsies revealed non-caseating granulomatous inflammation, and chest CT indicated pulmonary involvement. Infectious causes of granulomatous disease, including Mycobacterium tuberculosis, non-tuberculous mycobacteria, and fungal infections, were excluded through com-prehensive testing. The patient initially received conventional systemic corticosteroid therapy but developed treatment-related complications. Due to the need for sustained disease control, an alternative regimen combining low-dose corticosteroids with the selective JAK1 inhibitor abrocitinib was initiated. The patient showed significant clinical improvement following the combination therapy, with no observed treatment-related adverse events. This case suggests that low-dose corticosteroids combined with a JAK1 inhibitor such as abrocitinib may represent a treatment option for patients with sarcoidosis.
- 4 September 2025
- Published by Taylor & Francis in Journal of Dermatological Treatment
- Vol. 36 (1) , 2556487
Open AccessAbrocitinib combined with low-dose corticosteroids in the management of tattoo-related cutaneous sarcoidosis: a case report
Sarcoidosis is a chronic, multisystem granulomatous disorder characterized histologically by non-caseating granulomas. Despite the availability of various therapeutic options, long-term disease control remains a significant clinical challenge. We report the case of a 55-year-old female diagnosed with sarcoidosis. Skin and lymph node biopsies revealed non-caseating granulomatous inflammation, and chest CT indicated pulmonary involvement. Infectious causes of granulomatous disease, including Mycobacterium tuberculosis, non-tuberculous mycobacteria, and fungal infections, were excluded through com-prehensive testing. The patient initially received conventional systemic corticosteroid therapy but developed treatment-related complications. Due to the need for sustained disease control, an alternative regimen combining low-dose corticosteroids with the selective JAK1 inhibitor abrocitinib was initiated. The patient showed significant clinical improvement following the combination therapy, with no observed treatment-related adverse events. This case suggests that low-dose corticosteroids combined with a JAK1 inhibitor such as abrocitinib may represent a treatment option for patients with sarcoidosis.
- 29 May 2025
- Published by SAGE Publications in Journal of Cutaneous Medicine and Surgery
Favre-Racouchot Syndrome
- 29 May 2025
- Published by SAGE Publications in Journal of Cutaneous Medicine and Surgery
Favre-Racouchot Syndrome
- 20 May 2025
- Published by SAGE Publications in Journal of Cutaneous Medicine and Surgery
- Vol. 29 (3) , 324
Verruciform Xanthoma
- 20 May 2025
- Published by SAGE Publications in Journal of Cutaneous Medicine and Surgery
- Vol. 29 (3) , 324
Verruciform Xanthoma